Helms, S., Müller, C., & Melzer, N. (2021). Tocilizumab-Induced Limbic Encephalitis: Another Adverse Effect of Disrupted IL-6 Signalling?. Archives of Clinical and Medical Case Reports, 5(5), 704–709. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22542